Now a Chronic Illness?
An emerging view of myeloma is that it will be something that people die with and not die from. Dr. Kenneth Anderson, International myeloma expert, in October 2009, said “the last three years have been fantastic, but the best is yet to come.”
New therapies are overcoming genetic abnormalities that were once considered high risk in myeloma. Cutting-edge genomic techniques classify patients better. Ultimately this personalized or individualized medicine, defining the right treatment for the right patient at the right time, will revolutionalize treatment for myeloma.
